Adiponectin is an adipose-derived hormone that plays an important role in maintaining energy homeostasis. Adiponectin gene expression is diminished in both obesity and type 2 diabetes. However, the mechanism underlying the impaired adiponectin gene expression remains poorly understood. Recent studies have indicated that forkhead transcription factor O1 (Foxo1) and silent information regulator 2 mammalian ortholog SIRT1 are involved in adipogenesis. Here we have shown that Foxo1 up-regulates adiponectin gene transcription through a Foxo1-responsive region in the mouse adiponectin promoter that contains two adjacent Foxo1 binding sites. Foxo1 interacts with CCAAT/enhancer-binding protein ␣ (C/EBP␣) to form a transcription complex at the mouse adiponectin promoter and up-regulates adiponectin gene transcription. Our study has revealed that C/EBP␣ accesses the adiponectin promoter through two Foxo1 binding sites and acts as a co-activator. Further, SIRT1 increases adiponectin transcription in adipocytes by activating Foxo1 and enhancing Foxo1 and C/EBP␣ interaction. Importantly, both Foxo1 and SIRT1 protein levels were significantly lower in epididymal fat tissues from db/db and high fat diet-induced obese mice compared with normal mice. We propose that low expression of SIRT1 and Foxo1 leads to impaired Foxo1-C/EBP␣ complex formation, which contributes to the diminished adiponectin expression in obesity and type 2 diabetes.Adiponectin is an adipocyte-derived hormone that plays an important role in energy metabolism, immunological responses, and development of cardiovascular disease (1-3). Compelling evidence demonstrates that adiponectin enhances insulin sensitivity, improves fatty acid oxidation in skeletal muscle, and suppresses hepatic gluconeogenesis (4 -7). Although adiponectin is predominantly produced by adipose tissues, plasma adiponectin concentration and adiponectin gene expression are inversely correlated with adiposity (2).However, information is limited regarding the underlying mechanisms that impair adiponectin gene expression in obesity and type 2 diabetes. Foxo1 2 is a member of the forkhead transcription factor class O family and is involved in adipocyte differentiation (8). Foxo1 gene haploinsufficiency leads to significant reduction of adiponectin gene expression in the adipose tissue (8). SIRT1 is an NAD ϩ -dependent protein deacetylase that is also involved in adipogenesis (9). Calorie restriction induces Foxo1 and SIRT1 expression, which mediate the resultant longevity effect in cells from yeast to mammals (10, 11). The expression of Foxo1 and SIRT1 is also up-regulated during adipocyte differentiation (8, 9). SIRT1 regulates Foxo1 transactivation activity by deacetylating three lysine residues within the forkhead DNA binding domain (12). These studies led us to hypothesize that Foxo1 and SIRT1 may regulate adiponectin gene expression.Here, we report that overexpression of Foxo1 increased adiponectin gene expression in differentiated 3T3-L1 adipocytes. Our study has identified two Foxo1 respon...